Direct hemoperfusion with a polymyxin B-immobilized cartridge in intestinal warm ischemia reperfusion

World Journal of Gastroenterology

Volumn 14, Issue 35, 2008, Pages 5436-5441

  Sato, Hiroaki ^a   Oshima, Kiyohiro ^b   Arakawa, Kazuhisa ^a   Kobayashi, Katsumi ^a   Yamazaki, Hodaka ^a   Suto, Yujin ^a   Takeyoshi, Izumi ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GUNMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Interleukin 10; Ischemia reperfusion injury; PMX; Polymyxin B immobilized hemoperfusion cartridge

Indexed keywords

INTERLEUKIN 10; POLYMYXIN B; ENDOTOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL BLOOD; ARTERIAL PRESSURE; ARTERY CLAMP; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HEMOPERFUSION; INTESTINE BLOOD FLOW; INTESTINE INJURY; INTESTINE ISCHEMIA; MALE; MEDICAL INSTRUMENTATION; NONHUMAN; PH MEASUREMENT; PROTEIN BLOOD LEVEL; REPERFUSION INJURY; SUPERIOR MESENTERIC ARTERY OBSTRUCTION; VEIN OCCLUSION; ANIMAL; BIOSYNTHESIS; BLOOD; BLOOD FLOW VELOCITY; BLOOD PRESSURE; DISEASE MODEL; DOG; INJURY; INSTRUMENTATION; ISOLATION AND PURIFICATION; METHODOLOGY; PATHOPHYSIOLOGY; PH; SMALL INTESTINE; TEMPERATURE; VASCULARIZATION;

ANIMALS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; DOGS; ENDOTOXINS; FEMALE; HEMOPERFUSION; HYDROGEN-ION CONCENTRATION; INTERLEUKIN-10; INTESTINE, SMALL; MALE; POLYMYXIN B; REPERFUSION INJURY; TEMPERATURE;

EID: 64849092846     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.5436     Document Type: Article

References (25)

1. Tjärnström J, Wikström T, Bagge U, Risberg B, Braide M. Effects of hyperbaric oxygen treatment on neutrophil activation and pulmonary sequestration in intestinal ischemia-reperfusion in rats. Eur Surg Res 1999; 31: 147-154
2. Collard CD, Gelman S. Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology 2001; 94: 1133-1138
3. Köksoy C, Kuzu MA, Kuzu I, Ergun H, Gürhan I, Ergun H, Gurhan I. Role of tumour necrosis factor in lung injury caused by intestinal ischaemia-reperfusion. Br J Surg 2001; 88: 464-468
4. Koike K, Moore FA, Moore EE, Read RA, Carl VS, Banerjee A. Gut ischemia mediates lung injury by a xanthine oxidase-dependent neutrophil mechanism. J Surg Res 1993; 54: 469-473
5. Tsuzuki H, Tani T, Ueyama H, Kodama M. Lipopolysaccharide: neutralization by polymyxin B shuts down the signaling pathway of nuclear factor kappaB in peripheral blood mononuclear cells, even during activation. J Surg Res 2001; 100: 127-134
6. Shoji H. Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin). Ther Apher Dial 2003; 7: 108-114
7. Tani T, Hanasawa K, Kodama M, Imaizumi H, Yonekawa M, Saito M, Ikeda T, Yagi Y, Takayama K, Amano I, Shimaoka H, Ohta M, Okahisa T, Koga N, Fujita N, Yamasa H. Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator inhibitor-1 activities in septic patients. World J Surg 2001; 25: 660-668
8. Vincent JL, Laterre PF, Cohen J, Burchardi H, Bruining H, Lerma FA, Wittebole X, De Backer D, Brett S, Marzo D, Nakamura H, John S. A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 2005; 23: 400-405
9. Kushi H, Miki T, Okamaoto K, Nakahara J, Saito T, Tanjoh K. Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation. Crit Care 2005; 9: R653-R661
10. Oshima K, Akao T, Kobayashi K, Muraoka M, Matsumoto K, Takeyoshi I. The effect of direct hemoperfusion with a polymyxin B-immobilized fiber column (DHP-PMX therapy) on pulmonary ischemia-reperfusion injury in a canine model. J Invest Surg 2008; 21: 127-132
11. Iwanami K, Takeyoshi I, Ohwada S, Kobayashi J, Kawata K, Matsumoto K, Morishita Y. Intramucosal pH and intestinal mucosal damage in ischemia-reperfusion injury. Transpl Int 1998; 11: 401-407
12. King RC, Binns OA, Rodriguez F, Kanithanon RC, Daniel TM, Spotnitz WD, Tribble CG, Kron IL. Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 2000; 69: 1681-1685
13. Cohen J, Aslam M, Pusey CD, Ryan CJ. Protection from endotoxemia: a rat model of plasmapheresis and specific adsorption with polymyxin B. J Infect Dis 1987; 155: 690-695
14. Aoki H, Kodama M, Tani T, Hanasawa K. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber. Am J Surg 1994; 167: 412-417
15. Tetta C, Gianotti L, Cavaillon JM, Wratten ML, Fini M, Braga M, Bisagni P, Giavaresi G, Bolzani R, Giardino R. Coupled plasma filtration-adsorption in a rabbit model of endotoxic shock. Crit Care Med 2000; 28: 1526-1533
16. Uriu K, Osajima A, Hiroshige K, Watanabe H, Aibara K, Inada Y, Segawa K, Anai H, Takagi I, Ito A, Kamochi M, Kaizu K. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock. Am J Kidney Dis 2002; 39: 937-947
17. Kawamata T, Imaizumi H, Yoshida M, Kaneko M. Polymyxin B-immobilized fiber improves hyperdynamic state in MRSA septic patients. Intensive Care Med 1997; 23: 130-131
18. Kushi H, Nakahara J, Miki T, Okamoto K, Saito T, Tanjo K. Hemoperfusion with an immobilized polymyxin B fiber column inhibits activation of vascular endothelial cells. Ther Apher Dial 2005; 9: 303-307
19. Ohki S, Oshima K, Takeyoshi I, Matsumoto K, Morishita Y. Endotoxin removal with a polymyxin B-immobilized hemoperfusion cartridge improves cardiopulmonary function after cardiopulmonary bypass. J Surg Res 2008; 145: 74-79
20. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815-3822
21. Dimopoulou I, Armaganidis A, Douka E, Mavrou I, Augustatou C, Kopterides P, Lyberopoulos P, Tzanela M, Orfanos SE, Pelekanou E, Kostopanagiotou G, Macheras A, Giamarellos-Bourboulis EJ. Tumour necrosis factor-alpha (TNFalpha) and interleukin-10 are crucial mediators in postoperative systemic inflammatory response and determine the occurrence of complications after major abdominal surgery. Cytokine 2007; 37: 55-61
22. Wu B, Iwakiri R, Ootani A, Fujise T, Tsunada S, Fujimoto K. Platelet-activating factor promotes mucosal apoptosis via FasL-mediating caspase-9 active pathway in rat small intestine after ischemia-reperfusion. FASEB J 2003; 17: 1156-1158
23. Zingarelli B, Yang Z, Hake PW, Denenberg A, Wong HR. Absence of endogenous interleukin 10 enhances early stress response during post-ischaemic injury in mice intestine. Gut 2001; 48: 610-622
24. Malleo G, Mazzon E, Genovese T, Di Paola R, Caminiti R, Esposito E, Bramanti P, Cuzzocrea S. Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome. Cytokine 2008; 41: 136-143
25. Wang Y, Liu Y, Sarker KP, Nakashima M, Serizawa T, Kishida A, Akashi M, Nakata M, Kitajima I, Maruyama I. Polymyxin B binds to anandamide and inhibits its cytotoxic effect. FEBS Lett 2000; 470: 151-155